Last $5.08 USD
Change Today +0.10 / 2.01%
Volume 45.7K
CCXI On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 09/16/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Thomas J. Schall Ph.D.

Founder, Chairman, Chief Executive Officer and President, ChemoCentryx, Inc.
AgeTotal Calculated CompensationThis person is connected to 16 board members in 1 different organizations across 1 different industries.

See Board Relationships
55$2,315,889
As of Fiscal Year 2013

Background*

Dr. Thomas J. Schall, Ph.D. founded ChemoCentryx Inc. in November 1996 and has been its Chief Executive Officer and President since November 1996. Dr. Schall focuses on the discovery and development of chemokine-based therapeutics widely regarded as a Leader in chemokine research, his laboratories have been responsible for the discovery or co-discovery of almost one-third of all known chemokine receptors. From December 1993 to November 1996, he worked at the DNAX ResearchInstitute, ...

Read Full Background

Corporate Headquarters*

850 Maude Avenue
Mountain View, California 94043

United States

Phone: 650-210-2900
Fax: 650-210-2910

Board Members Memberships*

1996-Present
Founder, Chairman, Chief Executive Officer and President

Education*

PhD
The Leland Stanford Junior University
BS
Northern Illinois University

Other Affiliations*

Annual Compensation*

Salary$510,000
Total Annual Compensation$510,000

Stock Options*

All Other Compensation$690
Exercisable Options1,341,697
Unexercisable Options547,557
Total Number of Options1,889,254

Total Compensation*

Total Annual Cash Compensation$721,065
Total Short Term Compensation$510,000
Other Long Term Compensation$690
Total Calculated Compensation$2,315,889
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CCXI:US $5.08 USD +0.10

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Lamberto Andreotti Chief Executive Officer, Director, Member of Executive Committee and Member of Securities Issuance Committee
Bristol-Myers Squibb Company
$1.7M
George A. Scangos Ph.D.Chief Executive Officer and Director
Biogen Idec Inc.
$1.5M
Erez Vigodman Chief Executive Officer, President, Director, Member of Audit Committee and Member of Finance & Invesment Committee
Teva Pharmaceutical Industries Limited
--
Herve Hoppenot Chief Executive Officer, President and Director
Incyte Corporation
--
Yasuchika Hasegawa Chairman of the Board and Chief Executive Officer
Takeda Pharmaceutical Company Limited
--
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CHEMOCENTRYX INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.